Media Center

01-Jun-2023
Collaborator Release

Family resemblance: How T cells could fight many coronaviruses at once

LJI researchers work to head off future pandemics by uncovering key similarities between SARS-CoV-2 and common cold coronaviruses

29-Mar-2023
Collaborator Release

Scientists aim to develop vaccine against all deadly coronaviruses

$8 million NIH grant supports effort to avert next pandemic

24-Mar-2023
Collaborator Release

What are the Drivers of Chronic Infectious Disease?

A $1 million grant from the Steven & Alexandra Cohen Foundation will launch a UC San Diego-led national effort to more deeply study tissue samples from patients with conditions ranging from long COVID-19 and relapsed Lyme disease to chronic fatigue syndrome

The Tissue Analysis Pipeline will be directed by scientists at UC San Diego and the J. Craig Venter Institute

23-Feb-2023
Collaborator Release

BullFrog AI Partners with J. Craig Venter Institute to Develop Colorectal Cancer Therapeutic

Collaboration seeks to develop an oncolytic virus that incorporates a novel, precision-targeted approach to improve safety and efficacy

26-Jan-2023
Collaborator Release

Therapeutic Potential of Bizarre ‘Jumbo’ Viruses Tapped for $10M HHMI Emerging Pathogens Project

UC San Diego leads initiative aiming to develop bacteriophages as solutions for antibiotic resistance crisis

21-Jul-2022
Press Release

Synthetic genomics advances and promise

Advances in DNA synthesis will enable extraordinary new opportunities in medicine, industry, agriculture, and research

Pages

JCVI Scientists and Interns Dramatically Trim Proteome Analysis Costs with New Lab-on-a-Filter Process

Through a happy accident and a keen mind, JCVI intern Rodrigo Eguez realized scientists might be able to pack their own filters rather than rely on those produced commercially at a significant cost savings. While playing around in the laboratory, he inadvertently disassembled a filter device...

Unique Antibody Pattern Discovered in COVID-19 ICU Patients May Be Key to Predicting Severe Outcomes

While news of promising COVID-19 vaccine trials is heartening, the fight to control infection rates and develop effective treatments will be an ongoing challenge for science for years to come. Gene Tan, PhD and his collaborators are working on identifying...

Synthetic Cell-Powered Lotion to Manage Type 1 Diabetes

Early last year we first talked about how researchers Yo Suzuki, PhD, and John Glass, PhD at JCVI set out to eliminate the need for type 1 diabetes (T1D) patients to receive insulin injections to manage blood glucose levels through a novel approach: developing a bacterial replacement for beta...

COVID-19 Further Complicating Flu Season

While the world is rightly focused on the ongoing COVID-19 pandemic, it’s important to know that influenza is always a significant public health burden, and the combination of the pandemic and flu season could converge to become a perfect storm of infectious diseases. Influenza causes 3 to...

Sara Josephine Baker

At the beginning of the 20th century, many people remained skeptical of both germ theory and preventative medicine, but pioneering physician Dr. Sara Josephine Baker fought to revolutionize public health and is credited with saving tens of thousands of lives. After studying chemistry and...

JCVI Researchers Help Advance Our Understanding of Ocean Microbes, Developing New Tools and Protocols Through Large-Scale Study

The oceans cover over two-thirds of the Earth’s surface and contain an abundance of life including diverse populations of marine microbes.  Studying the  genetics, biochemistry and metabolism of these microbes has been one of JCVI’s long standing research initiatives and is...

Online Education Resources to Help With Your New “Normal”

The COVID-19 pandemic has brought many changes to our daily lives and routines, including for many of you the role of an at-home educator for your children due to open-ended school closures.  While we also miss directly connecting with students from our community, JCVI remains committed...

Coronavirus Pandemic: Putting Comprehensive Genomic Data in the Hands of Frontline Researchers Worldwide is Paramount

According to the CDC, SARS-CoV-2, the virus causing COVID-19, has now been detected in more than 150 countries/locations internationally. The World Health Organization (WHO) has declared COVID-19 a pandemic, and in the United States it has been declared it a national emergency. As...

Characterization of Bacteria from the International Space Station Drinking Water

From a microbiology perspective, the International Space Station (ISS) is interesting considering its microgravity, increased radiation, low humidity and elevated carbon dioxide levels. Because of its isolation, and unique environment, it is vital to study the microorganisms that thrive there...

Pages

10-Jan-2020
Issues in Science and Tech

Gene Drives: New and Improved

As the science advances, policy-makers and regulators need to develop responses that reflect the latest developments and the diversity of approaches and applications.

13-Nov-2019
The San Diego Union-Tribune

Pink shoes and a lab jacket: Finding your way as a female scientist

Women in science tell high school girls they, too, can change the world

01-Jun-2019
Asia Times

How AI can help us decode immunity

Artificial intelligence and machine learning will be the keys to unraveling how the human immune system prevents and controls disease

30-May-2019
Nature News and Views

Construction of an Escherichia coli genome with fewer codons sets records

The biggest synthetic genome so far has been made, with a smaller set of amino-acid-encoding codons than usual — raising the prospect of encoding proteins that contain unnatural amino-acid residues.

30-May-2019
UC San Diego News Center

Public Health is the Next Big Thing at UC San Diego

15-May-2019
MIT Technology Review

Researchers have swapped the genome of gut germ E. coli for an artificial one

By creating a new genome, scientists could create organisms tailored to produce desirable compounds

Pages

Logos

The JCVI logo is presented in two formats: stacked and inline. Both are acceptable, with no preference towards either. Any use of the J. Craig Venter Institute logo or name must be cleared through the JCVI Marketing and Communications team. Please submit requests to info@jcvi.org.

To download, choose a version below, right-click, and select “save link as” or similar.

Images

Following are images of our facilities, research areas, and staff for use in news media, education, and noncommercial applications, given attribution noted with each image. If you require something that is not provided or would like to use the image in a commercial application please reach out to the JCVI Marketing and Communications team at info@jcvi.org.